已收录 268921 条政策
 政策提纲
  • 暂无提纲
Camparision Results of Administration of Glucoseamine and Glucoseamine with Alendronate in Symptomatic Relieve of Knee DJD
[摘要] BackgroundandObjective:DegenerativeJointdisease(DJD)isthemostcommonjointdiseaseinhumanandthemostcauseofchronicdisabilityinagingpapulationindevelopedcountries.SeveralstudiesexplainthatglocosamineIsbetterthanplaseboanditsefficacyismoreincomparisonwithNSAIDinkneeosteoarthriticpatient.Alendronateisprescribedforosteoprothicpatients.Theaimofthisstudywastocomparetheefficacyofadminstrationofglocoseaminealoneandincombinationwithalendronateinosteoarthritisoftheknee.SubjectsandMethods:Atotalof130patientsofeithersexwithosteoarthritiswereincludedinthestudyandrandomisedtoreceiveglocoseaminealone(500mgTDS)andcombinationofGlocoseamine(500mgTDS)andalendronate(70mgweeky)for12weeks.Thepatientswereevaluatedat1;3;6and12weeksforefficacy.Results:Therewasnotstatisticalysignificantdecreaseinpainindex(pgt;0.05)butintotaltherapythemeanofpainisdecreased.Thestiffnesindexincombinationtherapywasdecreased(plt;0.05).Thefunctionofjointincombinationtherapywasimprovedafter12weeks.TheBMDafter12weekscombinationtherapywasimproved.Conclusion:Combinationtherapyofglocoseamineandalendronatewassignificantimprovementofstiffness,function,BMDofosteoarthritiscomparedwithglocoseaminealonebuttherewasnotstatisticallysignificantdecreasedinpainindex.Itcanbeconcludedthatthecombinationofglocoseaminewithalendronateprovidebetterandmorerapidimprovementinpatientswithosteoarthritis.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 基础医学
[关键词]  [时效性] 
   浏览次数:3      统一登录查看全文      激活码登录查看全文